FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference in New York City.
FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics has received conditional approval from the NYSDOH for its Neo Comprehensive Solid Tumor assay and NeoTYPE DNA & RNA Lung test.
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will report its third quarter 2024 financial results prior to the open of the U.S. financial markets on Tuesday, Nov. 5, 2024.
FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics' AML Express is an NGS assay designed to provide rapid, comprehensive genetic profiling for patients with acute myeloid leukemia.
Shares of NeoGenomics Inc (NEO, Financial) surged 3.95% in mid-day trading on Oct 2. The stock reached an intraday high of $14.36, before settling at $14.36, up from its previous close of $13.81.
FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announces new RaDaR technology and resolution of RaDaR 1.0 litigation.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.